Top Clean Energy Stocks To Own Right Now

Ethanol blends of 15%, or E15, just got a green light from the Supreme Court. Trade groups representing the oil, food, and automaker industries challenged that such high blends of ethanol would damage engines, raise food prices, and hike the price paid at the pump by consumers. The Supreme Court decided to leave current Environmental Protection Agency rules in place after the consortium (in three separate cases) failed to provide evidence that those claims were, in fact, harmful to its members. It sure isn't good news for the argument against E15, but it is vindication for ethanol producers. Since biofuels figure to be staying put with mandated growth for the time being, let's review four of the best biofuels stocks.

Clean Energy Fuels (NASDAQ: CLNE  ) The leader in compressed natural gas, or CNG, for the transportation industry got a boost from the EPA earlier this year when CNG sourced from landfills gained the ability to qualify for advanced biofuel subsidies. It's the next best thing to cellulosic ethanol credits, if not better. That can add a nice revenue stream to Clean Energy's already promising business model, and expedite its journey to profitability. Except for a tad more paperwork, the company doesn't have to change operations one bit. What's not to like?

Best Industrial Conglomerate Stocks To Own Right Now: mCig Inc (MCIG)

MCIG, INC. (mCig), incorporated on December 30, 2010, is a development-stage company. The Company is a technology company. The Company focused on two long-term secular trends sweeping the globe: the decriminalization and legalization of marijuana for medicinal or recreational purposes and the adoption of electronic vaporizing cigarettes (eCigs).

The mCig provides a smoking experience by heating (not burning) plant material, waxes, and oils delivering a smoother inhalation experience. As of October 31, 2013, the Company did not generate any revenues.

Advisors' Opinion:

• [By John Udovich]

  Last week, I talked about small cap electronic cigarette stocks Vapor Corp (OTCMKTS: VPCO) and Hop-On Inc (OTCMKTS: HPNN) as being among the last of the e-Cig�stocks not controlled by ��ig Tobacco,��but Victory Electronic Cigarettes Corp (OTCMKTS: ECIG), mCig Inc (OTCBB: MCIG) and American Heritage International (OTCBB: AHII)�are also�positioning themselves or their technology to exploit opportunities in the e-Cig market or even in�marijuana or cannabis. Last year, industry experts were already saying that�US retail sales of e-cigarettes could reach $1 billion for the year�for roughly�1% of the country's cigarette market. That number might appear small, but its more than double 2012 sales�as sales increasingly�move off the Internet and into more mainstream retailers thanks to their positioning as a���ealthier��alternative to smoking.

• [By Jason Shubnell]

  He also discussed MCIG (OTC: MCIG), a relatively new company that has developed a legal marijuana vaporizer, similar to the e-cig. The mCig heats plant material instead of burning it, providing a superior method of consumption that is much smoother, according to the company's website. The product sells for $10, while the stock itself has a market cap of $35 million.

Top Clean Energy Stocks To Own Right Now: ImmunoCellular Therapeutics Ltd (IMUC)

ImmunoCellular Therapeutics, Ltd., incorporated on March 20, 1987, is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors. Immunotherapy is an approach to treat cancer in which a patient�� own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies. The Company�� products include ICT-107, ICT-140, ICT-120, ICT-109 and DIAAD. ICT-107, the pipeline product, is a Phase II therapeutic dendritic cell (DC) vaccine for the treatment of glioblastoma multiforme (GBM), the common and lethal type of brain cancer. ICT-107 is designed to activate a patient�� immune system to target six different tumor-associated antigens. In February 2012, it acquired a world-wide license from the University of Pennsylvania and The John Hopkins University (JHU).

The Company in addition to ICT-107, is also developing other therapeutic DC vaccines: ICT-140 for ovarian cancer and ICT-121 for recurrent GBM. ICT-140 targets seven tumor-associated antigens expressed on ovarian cancer cells. ICT-107 is a DC vaccine that targets six different tumor-associated antigens that are found on patients��tumor cells; four of the six antigens are expressed on CSCs. The therapeutic vaccine is used subsequent to conventional therapy or concomitantly with chemotherapy in patients with newly diagnosed GBM. ICT-140 is a DC vaccine that targets seven different ovarian cancer antigens. ICT-121 is a DC vaccine that targets CD133 antigens; it has the potential to be a universal cancer vaccine because CD133 is widely expressed on CSCs from a majority of cancers. Data from this small study demonstrated that ICT-109 had a statistically ability to discriminate between cancerous and non-cancerous samples, suggesting the potential to detect pancreatic and lung cancer in plasma and serum study sets. The DIAAD (differential immunization for an! tigen and antibody discovery) platform it acquired from Molecular Discoveries utilizes immunological tolerization to accelerate the discovery of the molecular differences between diseased cells and their normal counterparts. The monoclonal antibodies produced by DIAAD provide the basis for the discovery and development of its potential diagnostic and therapeutic products.

The Company competes with Dendreon, Oncothyreon, Galena, Bavarian Nordic and Immunovaccine, Northwest Biotherapeutics, Prima Biomed, DCPrime, Roche/Genentech, Seattle Genetics, Bristol-Myers Squibb and Immunogen.

Advisors' Opinion:

• [By Monica Gerson]

  ImmunoCellular Therapeutics (NYSE: IMUC) dropped 11.05% to $1.3699. ImmunoCellular's trailing-twelve-month ROE is -59.80%.

  Posted-In: market losersNews Movers & Shakers Intraday Update Markets

• [By Smith On Stocks]

  Using my assumptions, the common of Agenus might be worth about $7.00 per share in early 2014 based on the royalties from the Glaxo vaccines and the net operating loss carry forward even if every other asset in the company were valued at zero. However, there may be substantial value in Agenus' internal vaccine programs in recurrent and newly diagnosed glioblastoma and the genital herpes vaccine. Based on a comparison to peer companies like Northwest Biotherapeutics (NWBO) and ImmunoCellular Therapeutics (IMUC), I believe that the internal programs at Agenus currently may be worth $150 million or $4.45 per share. Adding this to the value of the MAGE A-3 vaccine could produce a stock price of $11.00 in early 2014.

• [By Wallace Witkowski]

  Shares of ImmunoCellular (IMUC) �jumped after the drug developer said data on a mid-stage brain cancer drug study were looking encouraging.

• [By Lauren Pollock]

  ImmunoCellular Therapeutics Ltd.(IMUC) said its leading product candidate, a dendritic cell-based vaccine for brain cancer, didn’t show a statistically significant advantage in overall survival in a Phase II study. In a research note, Maxim Group said it is pushing its EU approval date target to 2019 and lowered its estimate on the stock to $12 a share from $18 a share. The stock plunged 62% to $1.04 premarket.

Top Clean Energy Stocks To Own Right Now: Potomac Electric Power Company(POM)

Pepco Holdings, Inc., through its subsidiaries, engages in the transmission, distribution, and supply of electricity. The company also distributes and supplies natural gas. It distributes electricity to approximately 1.8 million customers in the mid-Atlantic region and delivers natural gas to approximately 123,000 customers in Delaware. In addition, the company involves in the retail supply of electricity and natural gas; provision of energy efficiency services to federal, state, and local government customers; and designs, constructs, and operates combined heat and power and central energy plants, as well as owns and operates two oil-fired generation facilities. Further, it offers high voltage electric construction and maintenance services, low voltage electric construction and maintenance services, and streetlight construction and asset management services to utilities, municipalities, and other customers in the Washington, District of Columbia. Additionally, the company holds investments in eight cross-border energy leases. Pepco Holdings, Inc. was founded in 1896 and is based in Washington, District of Columbia.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Top Headline
  Pepco Holdings (NYSE: POM) reported a 35% rise in its fourth-quarter profit. For the year, Pepco projects earnings of $1.12 to $1.27 per share, versus analysts' estimates of $1.22 per share. Pepco's quarterly earnings surged to $58 million, or $0.23 per share, versus a year-ago profit of $43 million, or $0.18 per share. Excluding one ��ime items, its earnings from continuing operations came in at $0.24 per share. Its total operating revenue climbed 3.3% to $1.09 billion. However, analysts were expecting earnings of $0.21 per share on revenue of $1.11 billion.

Top Clean Energy Stocks To Own Right Now: Mediobanca Banca di Credito Finanziario SpA (MB)

Mediobanca Banca di Credito Finanziario SpA is an Italy-based bank. Together with its subsidiaries, the Company's activities are divided into three main segments: Corporate and Investment Banking (CIB), Principal Investing (PI) and Retail and Private Banking (RPB). In the CIB segment, the Bank is engaged in the investment banking activities, leasing services and trading investments. The PI segment comprises the Bank�� shareholdings in companies involved in the insurance sector, multimedia publishing activities and telecommunication services, as well as stakes acquired as part of merchant banking activity and investments in private equity funds. The RPB consists of financial products and services provided to retail customers, including consumer credit products, mortgages, deposit accounts, private banking and fiduciary activities. In September 2013, the Company launched the sale of its investment in Telco. Advisors' Opinion:

• [By Bloomberg]

  Mattel (MAT), the world's largest toymaker, agreed to buy Mega Brands (MB) for $460 million, acquiring the biggest challenger to Lego A/S in the construction-toy market. Mattel is offering C$17.75 ($16) a share, according to a statement today, a 36 percent premium over yesterday's closing price. The board of Montreal-based Mega Brands unanimously approved the transaction, and investors holding 39 percent of the stock, including Chief Executive Officer Marc Bertrand and Fairfax Financial Holdings (FFH), agreed to the deal. The purchase of Mega Brands, the world's second-largest maker of snap-together blocks, will fill a product hole for Mattel. It doesn't have its own construction line, locking it out of a $4 billion market in the U.S. and Europe. The category also is a bright spot in a toy industry that has seen growth stall in the U.S. Mattel considered starting its own construction line, then opted instead to buy Mega Brands because it would be faster and less risky, Mattel CEO Bryan G. Stockton said on a call with reporters. Mattel got its first taste of construction in 2012 when it debuted blocks for its Barbie brand through a licensing deal with Mega Brands. Mattel realized that replicating this kind of expertise would take years, Stockton said. 'About Growth' "This acquisition is all about growth," Stockton said. "We see an opportunity to expand our brands in this category across boys, girls and preschool." Mattel shares rose 0.8 percent to $37.44 at 10:34 a.m. in New York. They had declined 9 percent over the past year through yesterday. Shares of Montreal-based Mega Brands surged 36 percent to C$17.73 today in Toronto. Mattel is coming off a lackluster holiday season, with sales sinking 6.3 percent -- the biggest quarterly drop since 2009. The El Segundo, California-based toymaker has looked to acquisitions to boost sales in the past. In February of 2012, it paid $680 million to buy HIT Entertainment, owner of Thomas the Tank Engine. It also acq